SAR439859
Sanofi
['improve ', 'ameera-3', 'choice i', 'amcenestrant', 'bcsm', 'breast']
amcenestrant didn't statically improve pfs vs endocrine treatment of physician's choice in
patients with endocrine-resistant er+/her2- advanced breast cancer, results from ameera-3, a phase ii study presented by dr. sara tolaney at #esmo22 #bcsm 
MD, PhD, Medical Oncologist, interests #breastcancer #bcsm #gyncsm #ImmunoOnc #Immunotherapy #biomarkers #clinicaltrials @ASCO Views my own.